{"altmetric_id":2195163,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"blogs":{"unique_users_count":1,"unique_users":[55401],"posts_count":1},"googleplus":{"unique_users_count":1,"unique_users":["American Cancer Society Family of Journals"],"posts_count":1},"total":{"posts_count":4},"twitter":{"unique_users_count":2,"unique_users":["WITHealthScreen","JournalCancer"],"posts_count":2}},"citation":{"abstract":"Recently, men with intermediate-risk prostate cancer (PC) were classified into favorable and unfavorable categories; however, whether the risk of PC-specific mortality (PCSM) among men with high-risk PC versus unfavorable intermediate-risk PC is increased is unknown.","abstract_source":"pubmed","altmetric_jid":"4f6fa4e93cf058f610002494","authors":["Keane, Florence K.","Chen, Ming\u2010Hui","Zhang, Danjie","Loffredo, Marian J.","Kantoff, Philip W.","Renshaw, Andrew A.","D'Amico, Anthony V."],"doi":"10.1002\/cncr.28609","endpage":"1793","first_seen_on":"2014-03-18T19:34:04+00:00","isbns":[],"issns":["1097-0142","0008-543X"],"issue":"12","journal":"Cancer (0008543X)","last_mentioned_on":1395932280,"links":["http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cncr.28609\/abstract"],"pdf_url":"http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cncr.28609\/pdf","pmid":"24604289","pubdate":"2014-03-06T00:00:00+00:00","publisher":"John Wiley and Sons Inc.","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"1787","subjects":["neoplasms"],"title":"The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate\u2010risk disease","type":"article","volume":"120","mendeley_url":"http:\/\/www.mendeley.com\/research\/androgen-deprivation-therapy-risk-death-prostate-cancer-among-men-favorable-unfavorable-intermediate"},"altmetric_score":{"score":9.1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":9.1},"context_for_score":{"all":{"total_number_of_other_articles":6510893,"mean":6.0312903301097,"rank":672991,"this_scored_higher_than_pct":89,"this_scored_higher_than":5836469,"rank_type":"exact","sample_size":6510893,"percentile":89},"similar_age_3m":{"total_number_of_other_articles":152138,"mean":7.9526813727104,"rank":21061,"this_scored_higher_than_pct":86,"this_scored_higher_than":131034,"rank_type":"exact","sample_size":152138,"percentile":86},"this_journal":{"total_number_of_other_articles":3844,"mean":12.007774655217,"rank":800,"this_scored_higher_than_pct":79,"this_scored_higher_than":3043,"rank_type":"exact","sample_size":3844,"percentile":79},"similar_age_this_journal_3m":{"total_number_of_other_articles":129,"mean":14.001953125,"rank":32,"this_scored_higher_than_pct":75,"this_scored_higher_than":97,"rank_type":"exact","sample_size":129,"percentile":75}}},"demographics":{"poster_types":{"member_of_the_public":1,"science_communicator":1},"users":{"twitter":{"cohorts":{"Members of the public":1,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Professor > Associate Professor":2,"Student  > Doctoral Student":4,"Researcher":3,"Student  > Ph. D. Student":4,"Student  > Postgraduate":1,"Other":5,"Student  > Bachelor":2,"Lecturer":1},"by_discipline":{"Medicine and Dentistry":16,"Psychology":1,"Agricultural and Biological Sciences":3,"Unspecified":2}}},"geo":{"twitter":{"US":1},"mendeley":{"US":1,"DK":1,"ES":1}}},"posts":{"blogs":[{"title":"Prostate Cancer: Likelihood of Death from Intermediate Risk Disease","url":"http:\/\/medicalresearch.com\/cancer-_-oncology\/prostate-cancer\/prostate-cancer_likelihood_of_death_from_intermediate_risk_disease\/4461\/","citation_ids":[2195163],"posted_on":"2014-03-27T14:58:00+00:00","summary":"MedicalResearch.com Interview with: Florence K. Keane, MD Harvard Radiation Oncology Program, Harvard Medical School and Anthony V. D&rsquo;Amico, MD, PhD Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women&rsquo;s Hospital","author":{"name":"Medical Research News and Interviews: MedicalResearch.com","url":"http:\/\/medicalresearch.com","description":"Medical Research New and Research Interviews"}}],"googleplus":[{"title":"The lack of prostate cancer (PC) deaths in men with favorable intermediate-risk PC suggests that adding...","url":"https:\/\/plus.google.com\/102231633578632425378\/posts\/cg8AMU3MTh5","citation_ids":[2195163],"posted_on":"2014-03-18T19:30:26+00:00","summary":"The lack of prostate cancer (PC) deaths in men with favorable intermediate-risk PC suggests that adding... The lack of prostate cancer (PC) deaths in men with favorable intermediate-risk PC suggests that adding androgen-suppression therapy (AST) may not re","author":{"name":"American Cancer Society Family of Journals","url":"https:\/\/plus.google.com\/+AmericanCancerSocietyFamilyofJournals","image":"https:\/\/lh6.googleusercontent.com\/-nXBvEGR7us4\/AAAAAAAAAAI\/AAAAAAAAAA4\/8rBiCLpBvZw\/photo.jpg?sz=50","id_on_source":"102231633578632425378"}}],"twitter":[{"url":"http:\/\/twitter.com\/WITHealthScreen\/status\/446404684073676801","license":"public","rt":["JournalCancer"],"citation_ids":[2195163],"posted_on":"2014-03-19T21:55:45+00:00","author":{"name":"Health Screening","image":"https:\/\/pbs.twimg.com\/profile_images\/2162393594\/WIThealthscreen_avatar_normal.JPG","description":"Health Screening module for 3rd year Health Promotion Students at Waterford Institute of Technology, Ireland.","id_on_source":"WITHealthScreen","tweeter_id":"562229364","geo":{"lt":null,"ln":null},"followers":100},"tweet_id":"446404684073676801"},{"url":"http:\/\/twitter.com\/JournalCancer\/status\/446006623237312512","license":"public","citation_ids":[2195163],"posted_on":"2014-03-18T19:34:00+00:00","author":{"name":"ACS Journal Cancer","url":"http:\/\/www.canceronlinejournal.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/708058565030907904\/JjiXwvyC_normal.jpg","description":"An interdisciplinary journal of the American Cancer Society.\n&emsp;&emsp;&emsp;&emsp;\nEditor-in-Chief: Fadlo R. Khuri, MD (@DrFadloKhuri)","id_on_source":"JournalCancer","tweeter_id":"19077568","geo":{"lt":33.749,"ln":-84.38798,"country":"US"},"followers":19955},"tweet_id":"446006623237312512"}]}}